Liver problems may reduce the effectiveness of oral minoxidil due to impaired SULT1A1 enzyme activity, which is crucial for converting minoxidil to its active form. This reduction in enzyme function can significantly decrease the drug's effectiveness in promoting hair growth.
Topical finasteride is considered safer for the liver than oral finasteride due to less systemic absorption, but regular liverfunction tests are advised. The user is concerned about liver health due to a history of NAFLD and is exploring topical finasteride as a safer alternative.
Finasteride may cause elevated liver enzymes, potentially leading to liver issues, though this is rare. Users should monitor liverfunction and consider topical alternatives if liver sensitivity occurs.
The user is experiencing hair loss and is considering using topical minoxidil and finasteride due to concerns about liver health, specifically elevated ALT levels from fatty liver. They are advised to start with topical treatments while continuing weight loss and dietary changes to improve liverfunction.
Finasteride may affect liverfunction and cortisol levels, potentially linking it to non-alcoholic fatty liver disease (NAFLD). More research is needed to understand this connection fully.